Menu Search
Equities

PW Medtech Group Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
PWE:FRA

PW Medtech Group Ltd

Actions
  • Price (EUR)0.128
  • Today's Change0.004 / 3.23%
  • Shares traded2.63k
  • 1 Year change+29.29%
  • Beta0.1980
Data delayed at least 15 minutes, as of Feb 06 2026 07:04 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

PW Medtech Group Ltd is a company principally engaged in the research and development (R&D) and sales of medical devices. The Company operates its businesses through three segments. Infusion Set Business segment is mainly engaged in the R&D, manufacturing and sales of advanced infusion set, intravenous cannula products, insulin needles. Blood Purification Business segment is mainly involved in the R&D, manufacturing and sales of hemodialysis and blood purification medical devices. Regenerative Medical Biomaterials Business segment is mainly involved in the R&D and manufacturing of animal-derived tissue regenerative medical biomaterials and human tissue repair alternative product. The Company mainly operates its businesses in the domestic market.

  • Revenue in HKD (TTM)950.83m
  • Net income in HKD164.94m
  • Incorporated2011
  • Employees1.36k
  • Location
    PW Medtech Group LtdLevel 54Hopewell Centre, 183 Queen's Road EastBEIJING 101204ChinaCHN
  • Phone+86 1 084783617
  • Fax+86 1 084783657
  • Websitehttps://www.pwmedtech.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.